582 Results (Page 20 of 24)
US Markets Research Reports
US Preventive Healthcare Technologies and service Market Analysis
US Preventive Healthcare Technologies and Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Preventive Healthcare Technologies and Service is expanding as a result of rising incidence of chronic diseases and growing awareness among people. This demand is fueling the growth of Preventive Healthcare Technologies and Service market. Some of the key players in the global Preventive Healthcare Technologies and Service Market include Myriad Genetics, Inc., Quest Diagnostics Incorporated, Medtronic, Abbott, Merck & Co., GlaxoSmithKline plc, Omnicell, Inc., McKesson Corporation, Pfizer Inc., Dilon Medical Technologies, Inc., OMRON Healthcare Europe B.V., Novx Systems, Corp., U-Systems, Ltd., Viatronix, Inc., and Sanofi.
US Residential Nursing Care service Market Analysis
US Residential Nursing Care Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Residential Nursing Care Service is expanding as a result of rise in chronic diseases with growing geriatric population and growing nuclear families. This is fueling the demand for Residential Nursing Care Service market to provide support to these people. Some of the key players in the global Residential Nursing Care Service Market include The Ensign group, Inc., Kindred Healthcare, LLC, Genesis Healthcare, Brookdale Senior Living, Kaiser Permanente, CBI Health Group Inc., Trinity Health, Columbia Asia, Apollo Hospitals Enterprise Ltd., Grand World Elder Care, Knight Health Holdings, LLC, Inc., and Grand World Elder Care.
US Residential Substance Abuse and Mental Health Facilities Market Analysis
US Residential Substance Abuse and Mental Health Facilities Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Residential Substance Abuse and Mental Health Facilities is expanding as a result of rising prevalence of mental health disorders, innovation in healthcare, and improvements in healthcare infrastructure. This demand is growing the market for Residential Substance Abuse and Mental Health Facilities as more people avail these services. Some of the key players in the global Residential Substance Abuse and Mental Health Facilities Market Kaiser Permanente, Universal Health Services, Ohio Department of Mental Health and Addiction Services, NHS England, Acadia Healthcare Company, CareTech Holdings PLC, Pyramid Healthcare, The MENTOR Network, Behavioral Health Network, Inc., and Strategic Behavioral Health.
US Retirement Communities Market Analysis
US Retirement Communities Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Retirement Communities is expanding as a result of growing baby boomers and changing social norms of the family. This is fueling the demand for Retirement Communities market to provide support to these people. Some of the key players in the global Retirement Communities Market include Brookdale Senior Living Inc., Sunrise Senior Living, Atria Senior Living Group, Life Care Centers of America, Erickson Living, Holiday Retirement, Senior Lifestyle Corp., Affinity Living Group, HC-One Ltd., and Covenant Retire Communities Inc.
US Revenue Cycle Management Market Analysis
US Revenue Cycle Management Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The Revenue Cycle Management market is expanding due to huge growth opportunities created by expanding SMEs across the regions and increasing demand for workflow optimization in both developed and developing nations. This demand is fueling the development of better software systems and procedures for Revenue Cycle Management. Some of the key players in the global Revenue Cycle Management Market include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., McKesson Corporation, GE Healthcare, Quest Diagnostics, NextGen Healthcare, Inc., eClinicalWorks, and R1 RCM Inc.
US Revenue Cycle Management Software Market Analysis
US Revenue Cycle Management Software Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Revenue Cycle Management Software is expanding as a result of huge growth opportunities created by expanding SMEs across the regions and increasing demand for workflow optimization in both developed and developing nations. This demand is fueling the development of better software systems and procedures for Revenue Cycle Management. Some of the key players in the global Revenue Cycle Management Software Market include Cerner Corporation, Epic Systems Corporation, McKesson Corporation, Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., eClinicalWorks LLC, GE Healthcare, NextGen Healthcare, Inc., Quest Diagnostics Incorporated, and Siemens Healthineers AG.
US Sepsis Diagnostic Market Analysis
US Sepsis Diagnostics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Sepsis diagnostics is expanding as a result of the growing burden of infectious diseases and government initiatives and funding in both developed and developing nations. This demand is fueling the development of better diagnostic tools and methods for early diagnosis of sepsis. Some of the key players in the global Sepsis Diagnostics Market include bioM?rieux SA; Becton, Dickinson & Company; Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche AG; Danaher Corp. (Beckman Coulter, Inc.); Luminex Corp.; Bruker Corp.; Cepheid, Bruker Corporation, Immunexpress, Inc., and Koninklijke Philips N.V.
US Skilled Nursing Market Analysis
US Skilled Nursing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Skilled Nursing is expanding as a result of increasing geriatric population and increasing prevalence of chronic disease. Increasing demand for post-acute are is also fueling the need for specialized and skilled nursing in developing and developed countries. Some of the key players in the global Skilled Nursing Market include Genesis Healthcare Inc., Brookdale Senior Living Inc., Ensign Group Inc., Life Care Centers of America, Kindred Healthcare Inc., Extendicare Inc., Sunrise Senior Living, Atria Senior Living, SavaSeniorCare Administrative Services LLC., and Consulate Health Care.
US Soft Tissue Repair Market Analysis
US Soft Tissue Repair Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Soft Tissue Repair is expanding as a result of increasing sports-related injuries and a rising aging population. Increasing demand for non-invasive treatment and advancements in technology are fueling the soft tissue repair market. Some of the key players in the global soft tissue repair market are Smith & Nephew, Arthrex, Stryker Corporation, Baxter, Johnson & Johnson, Medtronic, LifeNet Health, Becton, Dickinson and Company, Integra Life Sciences Corporation, CryoLife, Boston Scientific Corporation, Zimmer Biomet, Baxter International, ACell, Tissue Regenix Group, and Aroa Biosurgery.
US Spinal Implant Market Analysis
US Spinal Implants Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Spinal Implants is expanding as a result of the rising prevalence of Spinal disorders, injuries, and fractures and the rising demand for advanced medical technology. Spinal cord injuries (SCI) are most common during road accidents and all of these spinal disorders are fueling the development of better procedures and devices for the implantation procedure of the spine. Some of the key players in the global Spinal Implants Market include Medtronic, Zimmer Biomet, Alphatec Spine Inc., RTI Surgical, Stryker, Orthofix US LLC, NuVasive Inc., Globus Medical, Aesculap Inc., Apollo Hospitals Enterprise Ltd., Centinel Spine LLC, Premia Spine, Exactech Inc., Aesculap Inc., Lumitex LLC, Life Spine Inc., and Integra LifeSciences
US Stem Cell/Cord Blood Banking Market Analysis
US Stem Cell/Cord Blood Banking Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stem Cell/ Cord Blood Banking is expanding as a result of increase in healthcare and growing awareness among people. This demand is fueling the development of market for Stem Cell/Cord Blood Banking. Some of the key players in the global Stem Cell/Cord Blood Banking Market include CBR Systems, Inc., Cordlife, Cryo-Cell International, Inc., ViaCord, Cryo-Save, LifeCell International Pvt. Ltd., StemCyte India Therapeutics Pvt. Ltd., Global Cord Blood Corporation, Smart Cells International Limited, and Vita 34 International.
US Stroke Management and Care Market Analysis
US Stroke Management and Care Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stroke Management and Care is growing as a result of rising prevalence of cardiovascular diseases, growing geriatric population, and advancements in technology. This demand is fueling the development of better care and management for stroke. Some of the key players in the global Stroke Management and Care Market include Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Bristol Myers Squibb Co., Merck & Co., GE Healthcare, Siemens AG, Cardinal Health Inc., GlaxoSmithKline Plc, and Medtronic Plc.
US Synthetic Biology Market Analysis
US Synthetic Biology Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Synthetic Biology is expanding as a result of rising demand for advancement in gene editing technology and genetic engineering in both developed and developing nations. This demand is fueling the development of better devices and methods for synthetic biology. Some of the key players in the global synthetic biology Market include Bota Biosciences Inc.; Codexis, Inc.; Creative Biogene; CREATIVE ENZYMES; Enbiotix, Inc.; Illumina, Inc.; Merck Kgaa (Sigma-Aldrich Co. LLC); New England Biolabs; Euro fins Scientific; Novozymes; Pareto Bio, Inc.; Scarab Genomics, LLC; Synthego; Synthetic Genomics Inc.; and Thermo Fisher Scientific, Inc.
US Thrombocytopenia Market Analysis
US Thrombocytopenia Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Thrombocytopenia is expanding as a result of increasing prevalence of thrombocytopenia and development of new treatment options. This demand is fueling the development of better devices and methods for the early and accurate diagnosis and treatment of Thrombocytopenia. Some of the key players in the global Thrombocytopenia Market include Sanofi, Principia Biopharma, Baxalta, Takeda, Argenx, Millennium Pharmaceuticals, Biotest, GC Pharma, Genosco (Subsidiary of Oscotec), Rigel Pharmaceuticals, Kissei Pharmaceutical, Shionogi & Co., Ltd, Amgen, Novartis, and Zenyaku Kogyo.
US Ultrasonic Technology Market Analysis
US Ultrasonic Technology Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Ultrasonic Technology is expanding as a result of rising chronic diseases and innovations in healthcare. This demand is fueling the growth of ultrasonic technology for the early detection and accurate diagnosis of various disease. Some of the key players in the global Ultrasonic Technology Market include Advanced Sonics, LLC, Crest Ultrasonics Corp., DPR Ultrasonic Technologies, Emerson Electric Co. (Branson), International Ultrasonic Technologies, Mosca GmbH, MS Industries AG, Sonotronic Nagel GmbH, Telsonic AG, and Ultrasonic Technologies, Inc.
US Urgent Care Center Market Analysis
US Urgent Care Center Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Urgent Care Center is expanding as a result of favorable government policies and increasing prevalence of chronic diseases and accidents. This demand is fueling the development of better infrastructures and facilities for urgent care center. Some of the key players in the global Urgent Care center market include Concentra, Inc.; American Family Care; CityMD Urgent Care; MedExpress Urgent Care; NextCare Urgent Care; Tenet Health Urgent Care; FastMed Urgent Care; Ascension Health Urgent Care; WellNow Urgent Care; Sutter Health; Aurora Urgent Care; and Intuitive Health.
US DNA Sequencing Market Analysis
US DNA Sequencing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for DNA Sequencing is expanding as a result of advances in DNA Sequencing technology and increased applications in clinical diagnosis drug discovery. This is raising the demand for the market and is leading to increased investment in research & development for DNA Sequencing. Some of the key players in the global DNA Sequencing Market include Aglient Technologies, Illumina, Inc., Hoffmann-La Roche Ltd., QIAGEN, Perkin Elmer, Thermo Fisher Scientific, Macrogen, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies Ltd., Myriad Genetic, and Pacific Biosciences.
US ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
The US ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market is projected to grow from $12.415 Bn in 2022 to $14.776 Bn by 2030, registering a CAGR of 2.20% during the forecast period of 2022-2030. The number of individuals diagnosed with ADHD is on the rise, leading to a higher demand for ADHD medications. Some of the key players in the US ADHD drugs market include Shire (now part of Takeda), Johnson & Johnson, Novartis, Pfizer, Eli Lilly and Company, Concert Pharmaceuticals, Aevi Genomic Medicine, Neos Therapeutics, Vayarin, Supernus Pharmaceuticals.
US Myasthenia Gravis Therapeutics Market Analysis
The US Myasthenia Gravis therapeutics market is projected to grow from $418.4 Mn in 2022 to $724.3 Mn by 2030, registering a CAGR of 7.1% during the forecast period of 2022-30. This market engages in all of these activities, including regulatory approvals, the introduction of new products, the purchase of other companies, and joint ventures with them. These strategies will definitely contribute to the growth of the global industry. Major global players in this market are Alexion Pharmaceuticals, Inc., Bausch Health Companies, Inc., Novartis AG, Amneal Pharmaceuticals LLC, Zydus Cadila, Avadel, Dr. Reddy's Laboratories, Ltd., Fresenius Kabi, AG, Endo Pharmaceuticals, Inc., Amphastar Pharmaceuticals, Inc., Mylan N.V., Aurobindo Pharma, Pfizer, Inc., and Astellas Pharma, Inc.
US Multiple Sclerosis Therapeutics Market Analysis
The US multiple sclerosis therapeutics market is projected to grow from $18.2 Bn in 2022 to $27.7 Bn by 2030, registering a CAGR of 5.38% during the forecast period of 2022?30. The two reasons propelling market expansion are the prevalence of multiple sclerosis (MS) is rising, and funding for MS research is rising as well. Major global players in this market are Abbott (U.S.), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Takeda Pharmaceutical Company Limited (Japan), Jazz Pharmaceuticals, Inc. (U.K.), Novartis AG (Switzerland), Biora Therapeutics, Inc. (U.S.), Bausch Health Companies Inc. (Canada), Pfizer Inc. (U.S.), Novartis AG (Switzerland), and Mylan N.V. (U.S.)
US Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
The US Chronic Obstructive Pulmonary Disease (COPD) therapeutics market was valued at $7.6 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030 and will reach $11.4 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of new therapies, a government initiative. The market is segmented by drug class and distribution channel. Some key players in this market are GlaxoSmithKline, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva US Limited, ResMed, Hill-Rom, and others.
US Rheumatology Drugs Market Analysis
The US Rheumatology Drugs Market is projected to grow from $25.641 Bn in 2022 to $27.329 Bn by 2030, registering a CAGR of 0.8% during the forecast period of 2022-2030. The development of new biologic drugs, such as tumour necrosis factor (TNF) inhibitors, interleukin (IL)-6 inhibitors, and Janus kinase (JAK) inhibitors, has expanded the treatment options for rheumatic conditions, driving the market growth. Pfizer is one of the leading pharmaceutical companies in the world and offers a range of rheumatology drugs, including TNF inhibitors and JAK inhibitors.
US ePharmacy Market Analysis
The US ePharmacy Market is projected to grow from $21 Bn in 2022 to $86 Bn by 2030, registering a CAGR of 19.3% during the forecast period of 2022-2030. The US ePharmacy market is driven by a number of factors, including the increasing demand for convenient and cost-effective healthcare solutions, the rise in chronic diseases and the aging population, and the growing adoption of technology in the healthcare industry. CVS Health is one of the largest ePharmacy players in the United States, with a market share of around 25%. The company offers a range of services, including prescription fulfillment, mail-order delivery, and specialty pharmacy services.
US Obesity Drugs Market Analysis
The US obesity drugs market is projected to grow from $1.2 Bn in 2022 to $5.2 Bn by 2030, registering a CAGR of 20.3% during the forecast period of 2022-30. There is increasing awareness of the health risks associated with obesity, including heart disease, diabetes, and high blood pressure. This is driving demand for effective treatments that can help reduce the risk of these conditions. Novo Nordisk, a Danish pharmaceutical company is a major player in the obesity drugs market, with a portfolio of products that includes Saxenda (liraglutide), an injectable drug approved for weight loss in adults with obesity.
US Healthcare Insurance Market Analysis
The US healthcare insurance market is projected to grow from $851 Bn in 2022 to $1316 Bn by 2030, registering a CAGR of 5.6% during the forecast period of 2022-30. The Affordable Care Act (ACA) passed in 2010 significantly impacted the US healthcare insurance market by mandating that individuals carry health insurance coverage and creating insurance marketplaces where consumers can compare and purchase health plans. UnitedHealth Group is the largest healthcare insurance company in the US, with over 50 Mn members across the country.
